Detalles de la búsqueda
1.
New Developments in the Treatment of Schizophrenia: An Expert Roundtable.
Int J Neuropsychopharmacol;
26(5): 322-330, 2023 05 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-36932673
2.
Caregiver-Reported Burden in RE-KINECT: Data From a Prospective Real-World Tardive Dyskinesia Screening Study.
J Am Psychiatr Nurses Assoc;
29(5): 389-399, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-34154444
3.
Current and future nonstimulants in the treatment of pediatric ADHD: monoamine reuptake inhibitors, receptor modulators, and multimodal agents.
CNS Spectr;
27(2): 199-207, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33121553
4.
A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder.
J Clin Psychopharmacol;
41(4): 370-380, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34181360
5.
RE-KINECT: A Prospective Study of the Presence and Healthcare Burden of Tardive Dyskinesia in Clinical Practice Settings.
J Clin Psychopharmacol;
40(3): 259-268, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32332461
6.
Good, better, best: clinical scenarios for the use of L-methylfolate in patients with MDD.
CNS Spectr;
25(6): 750-764, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31833826
7.
Clinical implications of directly switching antidepressants in well-treated depressed patients with treatment-emergent sexual dysfunction: a comparison between vortioxetine and escitalopram.
CNS Spectr;
25(1): 50-63, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31010445
8.
Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important difference.
Mov Disord;
34(8): 1203-1209, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31234240
9.
Evaluation of the long-term safety and tolerability of cariprazine in patients with schizophrenia: results from a 1-year open-label study.
CNS Spectr;
23(1): 39-50, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28478771
10.
Effect of aripiprazole lauroxil in patients with acute schizophrenia as assessed by the Positive and Negative Syndrome Scale-supportive analyses from a Phase 3 study.
CNS Spectr;
23(4): 284-290, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28625204
11.
Beyond the pill: new medication delivery options for ADHD.
CNS Spectr;
22(6): 463-474, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28683846
12.
The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis.
BMC Psychiatry;
17(1): 305, 2017 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-28836957
13.
PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury.
BMC Neurol;
16: 89, 2016 Jun 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27276999
14.
An open-label study to assess safety, tolerability, and effectiveness of dextromethorphan/quinidine for pseudobulbar affect in dementia: PRISM II results.
CNS Spectr;
21(6): 450-459, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-26471212
15.
Efficacy of cariprazine in patients with bipolar depression and higher or lower levels of baseline anxiety: a pooled post hoc analysis.
Int Clin Psychopharmacol;
39(2): 82-92, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37551609
16.
Estimating Changes in Weight and Metabolic Parameters Before and After Treatment With Cariprazine: A Retrospective Study of Electronic Health Records.
Clin Ther;
46(1): 50-58, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38036337
17.
Serdexmethylphenidate/dexmethylphenidate for children with attention-deficit/hyperactivity disorder: dose optimization from a laboratory classroom study.
Front Psychiatry;
15: 1310483, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38566957
18.
Long-term safety and tolerability of iloperidone: results from a 25-week, open-label extension trial.
CNS Spectr;
18(1): 43-54, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23312567
19.
A structured interview guide for global impressions: increasing reliability and scoring accuracy for CNS trials.
Ann Gen Psychiatry;
12(1): 2, 2013 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-23369692
20.
Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder.
Transl Psychiatry;
13(1): 228, 2023 06 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37365161